Medical management of osteoarthritis during the COVID-19 pandemic: a challenge for the present and the future
Keywords:
Osteoarthritis, COVID-19, telerehabilitation, injections, therapeutic continuity.Abstract
The ongoing Covid-19 pandemic has inevitably changed the treatment of many chronic diseases which has been suspended or has suffered dangerous slowdowns. Osteoarthritis (OA) is the most common musculoskeletal disease. As a result, the medical management of Osteoarthritis was heavily impacted by the pandemic, and it required new therapeutic strategies. The purpose of this descriptive review is to provide an overview of how much the pandemic has affected the medical management of osteoarthritis and to outline a number of possible countermeasures. The COVID-19 pandemic requires a “multimodal approach”: physicians are called to test the management of Osteoarthritis patients at a distance, through the tools made available by telemedicine, for all cases in which direct contact is avoidable. Therapies that instead require a direct intervention on the patient impose that all the procedures are carried out in complete safety, scrupulously keeping to the use of personal protective equipements.
References
1. Agostini F, Mangone M, Ruiu P, Paolucci T, Santilli V, Bernetti A. Rehabilitation setting during and after Covid-19: An overview on recommendations. J Rehabil Med. 2021 Jan 5; 53(1):
jrm00141. doi: 10.2340/16501977-2776.
2. Bernetti A, Mangone M, Paolucci T, et al. Evaluation of the efficacy of intra-articular injective treatment with reticular hyaluronic acid (Mo.Re. Technology) in amateur athletes with over-use gonarthrosis. Med Sport. 2020 Mar; 73(1): 12739. doi: 10.23736/S0025-7826.20.03648-0.
3. Masiero S, Maccarone MC, Agostini F. Health resort medicine can be a suitable setting to recover disabilities in patients tested negative for COVID-19 discharged from hospital? A challenge for the future. Int J Biometeorol. 2020 Oct; 64(10): 1807-9. doi: 10.1007/s00484-02001947-4. Epub 2020 Jun 5.
4. Voiriot G, Philippot Q, Elabbadi A, Elbim C, Chalumeau M, Fartoukh M. Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients. J Clin Med. 2019 Jun; 8(6): 786. doi: 10.3390/jcm8060786.
5. Ragni E, Mangiavini L, Viganò M, et al. Management of Osteoarthritis During the COVID19 Pandemic. Clin Pharmacol Ther. 2020 Oct; 108(4): 719-29. doi: 10.1002/cpt.1910. Epub 2020 Jun 22.
6. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. The Lancet Gastroenterol Hepatol. 2020 May; 5(5): 428-30. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
7. Farì G, Santagati D, Pignatelli G, et al. Collagen Peptides, in Association with Vitamin C, Sodium Hyaluronate, Manganese and Copper, as Part of the Rehabilitation Project in the Treatment of Chronic Low Back Pain. Endocr Metab Immune
Disord Drug Targets. 2021 Feb 10. doi: 10.2174 /1871530321666210210153619. Epub ahead of print.
8. Bernetti A, Mangone M, Villani C, et al. Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy. Eur J Phys Rehabil Med. 2019 Oct; 55(5): 658-64. doi: 10.23736/S1973-9087.19.05633-8. Epub 2019 May 15.
9. Boldrini P, Bernetti A, Fiore P; SIMFER Executive Committee, SIMFER Committee for International Affairs. Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine physicians’ activities in Italy. An official document of the Italian PRM Society (SIMFER). Eur J Phys Rehabil
Med. 2020 Jun; 56(3): 316-8. doi: 10.23736/ S1973-9087.20.06256-5. Epub 2020 Mar 16.
10. Karasavvidis T, Hirschmann MT, Kort NP, Terzidis I, Totlis T. Home-based management of knee osteoarthritis during COVID-19 pandemic: literature review and evidence-based recommendations. J Exp Orthop. 2020 Jul 19; 7(1):
52. doi: 10.1186/s40634-020-00271-5.
11. Mariconda C, Megna M, Farì G, et al. Therapeutic exercise and radiofrequency in the rehabilitation project for hip osteoarthritis pain. Eur J Phys Rehabil Med. 2020 Aug; 56(4): 451-8. doi: 10.23736/S1973-9087.20.06152-3. Epub 2020 Mar 10.
12. Paoloni M, Bernetti A, Belelli A, et al. Appropriateness of clinical and organizational criteria for intra-articular injection therapies in osteoarthritis. A Delphi method consensus initiative among experts in Italy. Ann Ist Super Sanita. 2015; 51(2): 131-8. doi: 10.4415/ANN_15_02_11.
13. Bai AV, Rabasco J, Ceccatelli V, et al. Suggestions for changes in professional procedures and adaptation to COVID-19: new models of care in the rehabilitation setting. Ann Ig. 2021 May-Jun; 33(3): 299-304. doi: 10.7416/ai.2021.2434.
14. Agostini F, Bernetti A, Di Giacomo G, et al. Rehabilitative Good Practices in the Treatment of Sarcopenia: A Narrative Review. Am J Phys
Med Rehabil. 2021 Mar 1; 100(3): 280-7. doi: 10.1097/PHM.0000000000001572.
15. Paoloni M, Di Sante L, Dimaggio M, et al. Kinematic and kinetic modifications in walking pattern of hip osteoarthritis patients induced by intra-articular injections of hyaluronic acid. Clin Biomech (Bristol, Avon). 2012 Aug; 27(7): 661-5. doi: 10.1016/j.clinbiomech.2012.02.004.
Epub 2012 Mar 11.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.